New York, March 01, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Clinical Decision Support Systems Market By Component, By Product,H),R),, Integrated E),H),R), with CDSS, and Others), By Delivery Mode, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027" - https://www.reportlinker.com/p06240978/?utm_source=GNW
This Domain 3 strategy, when applied to CVD prevention, can help providers in a variety of ways, such as reminding them to screen for CVD risk factors, flagging cases of hypertension or hyperlipidemia, providing information on treatment protocols, prompting questions about medication adherence, and providing tailored recommendations for health behavior changes.
According to the World Ageing 2019 report, the world’s population of people aged 65 and above was predicted to be 703 million in 2019. This group of people is prone to a variety of chronic diseases and requires regular health screenings and treatments to stay healthy. According to the current circumstances around the world, many people belonging to elderly and pregnant women segment, may require health examinations, but hospitals and clinics are unable to deliver these services owing to the global COVID-19 outbreak.
In recent years, a major increase in the number of hospitals and healthcare institutions that have adopted various forms and levels of clinical decision support systems has created a considerable opportunity for increased adoption in the near future. In industrialized regions, demand for decision assistance based on factual evidence and real-time knowledge has increased at a quicker adoption rate.
The number of agreements between CDSS providers and hospitals has increased significantly in recent years. Companies collaborate to develop and supply software that is up to date with the updated knowledge. The demand is expected to rise further as a result of government recognition and activities to stimulate the deployment of CDSS and EHR systems.
COVID-19 Impact Analysis
COVID-19 emerged as a very deadly infection that caused a significant number of deaths around the world. Additionally, the COVID-19 pandemic also devastated businesses across the world irrespective of their sizes. During the pandemic, the healthcare infrastructure of various companies failed due to the sudden outburst of the infection which resulted in an unexpected count of patients in urgent requirement of hospitalization. Resultantly, CDSS providers and groups have launched measures to aid in the fight against the pandemic.
CDSS has been shown to be an important weapon in the fight against COVID-19, demonstrating how healthcare teams can stay up to date on the newest COVID information and intelligence, hence improving the quality of treatment they give. Patients with a moderate to high chance of COVID-19 should have their COVID-19 test repeated, according to the Infectious Diseases Society of America.
Market Growth Factors:
The emergence of economies
Some of the growth catalysts for the market include the deployment of government policies boosting the adoption of HCIT solutions, rising government healthcare expenditure, and the availability of qualified IT experts in emerging countries around the world. Authorities in different countries are concentrating on revamping the healthcare management sector, which is currently confronting issues such as a statewide scarcity of doctors, underfunded rural health centers, overburdened metropolis hospitals, and confusing patient data systems.
Enhancement across clinical management
In various studies, it has been found that CDSS enhances adherence to clinical guidelines. Traditional clinical guidelines and treatment pathways have been demonstrated to be challenging to apply in practice due to low physician adherence. The expectation that practitioners will read, internalize, and apply new standards has not been shown to be true. The rules implicitly contained in recommendations, on the other hand, can be literally encoded in CDSS. CDSS can take many different forms, including standardized order sets for a certain case, alerts to a specific protocol for the patients involved, testing reminders, and so on.
Market Restraining Factors:
Technical difficulties and installation obstacles
In a variety of areas, clinical decision support systems encounter significant technical obstacles. Biological systems are extremely complex, and a therapeutic choice may rely on a vast amount of potentially relevant information. When recommending a patient’s course of treatment, an electronic evidence-based medicine system might take into account the patient’s symptoms, medical history, family history, and genetics, as well as historical and geographical trends in disease occurrence and published clinical data on medicinal effectiveness.
Component Outlook
Based on the Component, the Clinical delivery support systems market is categorized into Hardware, Software, and Services. In 2020, the hardware segment followed the services segment and obtained the second largest revenue share of the clinical decision support systems market. The increasing growth of this segment is attributed to the increasing manufacturing of CDSS in order to fulfill the demand of the healthcare sector. The hardware of these systems is widely being produced resulting in increasing the growth of this segment of the clinical decision support systems market.
Product Outlook
Based on the Product, the Clinical decision support systems market is segmented into Standalone CDSS, Integrated CPOE with CDSS, Integrated E.H.R. with CDSS, and Integrated CDSS with CPOE & E.H.R. In 2020, the standalone CDSS segment dominated the clinical decision support systems market by acquiring the largest revenue share of the market. This is owing to the low cost and simplicity of standalone CDSS. CDSS products can be used independently or in conjunction with an EHR or CPOE, or both.
Delivery Mode Outlook
Based on the Delivery mode, the Clinical decision support systems market is divided into Web-based Systems, Cloud-based Systems, and On-premise Systems. In 2020, the web-based systems segment acquired the second-largest revenue share of the clinical decision support systems market. The increasing growth of this segment of the market is attributed to the rising adoption of modern computers as well as continuous developments along with the latest innovations in software development.
Application Outlook
Based on the Application, the Clinical decision support systems market is segregated into Drug-drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines, Drug Dosing Support, and Others. In 2020, the clinical guidelines segment would showcase the promising growth rate during the forecasted period. Moreover, the growth of this segment accelerated due to the fact that the CDS system provides treatment and diagnosis guidelines. It pulls data from the knowledge base and applies it to treatment, offering therapeutic guidelines for the practitioner to follow throughout the treatment process and therefore increasing the quality of care.
Regional Outlook
Based on the Region, the Clinical decision support systems market is analyzed across North America, Europe, APAC, and LAMEA. In 2020, North America led the clinical decision support systems market by accounting for the largest revenue share of the market. The surge in demand for healthcare information technology solutions in the medical industry can be ascribed to the market’s growth. Rapid technology improvements, as well as the growing necessity of offering high-quality healthcare services, are driving the growth of the regional market.
The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; General Electric (GE) Co. is the major forerunner in the Clinical Decision Support Systems Market. Companies such as Siemens Healthineers AG, Change Healthcare, Inc., NextGen Healthcare, Inc. are some of the key innovators in the Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), AllScripts Healthcare Solutions, Inc., General Electric (GE) Co. (GE Healthcare), NextGen Healthcare, Inc., Athenahealth, Inc. (Veritas Capital), Epic Systems Corporation, eClinicalWorks LLC, Change Healthcare, Inc., and Zynx Health, Inc. (Hearst Communications, Inc.).
Recent strategies deployed in Clinical Decision Support Systems Market
Partnerships, Collaborations and Agreements:
Nov-2021: GE Healthcare collaborated with SOPHiA GENETICS, a biotechnology company. This collaboration helped GE Healthcare in supporting integrated health systems at the local level through delivering the technology for deploying software throughout imaging networks and helping to develop the newest innovations accessible across the broader population.
Aug-2021: Epic Systems came into partnership with Foundation Medicine, Inc. Following the partnership, the latter company combined its comprehensive genomic profiling (CGP) and other testing services with Epic’s electronic medical record systems. The combination was designed for supporting academic medical centers, oncology practices, and other health systems through offering access to genomic and clinical information easily in one place to better allow more streamlined clinical decision-making.
Jun-2021: Siemens Healthineers partnered with Prisma Health. Together, the companies focus on bringing breakthrough opportunities to increase clinical care with the latest medical technology, smoothening the processes, and creating new advances in disease prevention, diagnosis, and treatment.
May-2021: Athenahealth extended its collaboration with Nuance Communications. The expansion comprises the integration of Nuance’s cloud-based Dragon Medical that brings virtual assistant and speech technology to AthenaOne EHR and Mobile App. With the help of Nuance’s conversational AI Platform, AthenaOne Dictation users have the advantage of completely integrated, voice-driven capabilities. These capabilities allow clinicians to minimize documentation time and burden for improving the patient experience.
Jan-2021: Change Healthcare announced an agreement to merge with Optum, a UnitedHealth Group company. Under this agreement, Change Healthcare would join OptumInsight for offering software and data analytics, advisory and revenue cycle management, technology-enabled services, and research offering for helping make the health care network better.
Oct-2020: Athenahealth announced its partnership with RxRevu, the provider of prescription decision support solutions. The partnership focuses on deploying SwiftRx Direct, RxRevu’s real-time prescription benefit solution in Athenahealth’s EHR. This partnership brought patient-specific prescription pricing information to Athenahealth customers, enabling providers to view cost-effective medication options and coverage information for their patients.
Jul-2020: Cerner teamed up with Holon Solutions following which the companies aimed to deploy patented technology. This deployment aims to automate the delivery of patient data from Cerner’s EHR agnostic HealthIntent Population for keeping clinicians informed about relevant health information.
Product Launches and Product Expansions:
May-2021: GE Healthcare introduced Xeleris V, a virtual processing and review solution. The increase in access combined with AI-enabled applications and GE Healthcare’s large install base of nuclear medicine cameras simplify and accelerates workflows for helping the clinicians in discovering, diagnosing, and treating patients quickly with accuracy.
Apr-2021: Change Healthcare launched InterQual 2021. Four new Medicare criteria modules are included in the new release, along with many of the evidence-based content updates and refinements, including new guidelines on caring for COVID-19 patients, addressing socioeconomic determinants of health, and using telemedicine appropriately.
Apr-2020: GE Healthcare unveiled Mural Virtual Care Solution. This solution was developed for providing a broad view to hospitals throughout their ventilated patient population. Moreover, it helps in identifying the patients at risk of deterioration.
Scope of the Study
Market Segments covered in the Report:
By Component
• Services
• Hardware
• Software
By Product
• Standalone CDSS
• Integrated CDSS with CPOE & E.H.R.
• Integrated E.H.R. with CDSS
• Others
By Delivery Mode
• On-premise Systems
• Web-based Systems
• Cloud-based Systems
By Application
• Drug Allergy Alerts
• Drug-drug Interactions
• Clinical Guidelines
• Drug Dosing Support
• Clinical Reminders
• Others
By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled
• Siemens Healthineers AG (Siemens AG)
• Cerner Corporation (Oracle Corporation)
• AllScripts Healthcare Solutions, Inc.
• General Electric (GE) Co. (GE Healthcare)
• NextGen Healthcare, Inc.
• Athenahealth, Inc. (Veritas Capital)
• Epic Systems Corporation
• eClinicalWorks LLC
• Change Healthcare, Inc.
• Zynx Health, Inc. (Hearst Communications, Inc.)
Unique Offerings
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Read the full report: https://www.reportlinker.com/p06240978/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
